An Innovative Medicines Initiative Project for Precision Medicine in DKD
BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-¬¬year project (total budget 28
https://www.ludc.lu.se/article/innovative-medicines-initiative-project-precision-medicine-dkd - 2025-08-25